Abstract | BACKGROUND: METHODS: Tumour tissue of 100 patients with EOC was analysed for protein expression of vascular endothelial growth factor ( VEGF)-A, -C, -D by Western Blot analysis. Expression patterns in patients with 'extensive intraperitoneal' metastases (pT3c pN1 and pT3b-pT3c pN0, n=80) were compared to patients with 'predominantly retroperitoneal' metastases (pT1a-pT3b, pN1, n=20). Overall and progression-free survival was analysed by Kaplan-Meier method. RESULTS: While no significant differences in expression levels among the different modes of metastases were noted for VEGF-A and -D, VEGF-C expression was significantly higher in the group of predominantly retroperitoneal metastases compared to the group with extensive intraperitoneal metastases. Patients with high VEGF-C expression had a significantly worse overall survival compared to patients with low expression levels. CONCLUSIONS: Retroperitoneal tumour progression in EOC patients is associated with high VEGF-C expression. VEGF-C may serve as a molecular marker to identify patients with assumed high risk for lymphatic metastases, who might benefit from specific treatment strategies.
|
Authors | Sascha Kuerti, Leticia Oliveira-Ferrer, Karin Milde-Langosch, Barbara Schmalfeldt, Karen Legler, Linn Woelber, Katharina Prieske, Sven Mahner, Fabian Trillsch |
Journal | Oncotarget
(Oncotarget)
Vol. 8
Issue 26
Pg. 43218-43227
(Jun 27 2017)
ISSN: 1949-2553 [Electronic] United States |
PMID | 28591727
(Publication Type: Journal Article)
|
Chemical References |
- VEGFC protein, human
- Vascular Endothelial Growth Factor C
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Blotting, Western
- Disease Progression
- Female
- Humans
- Lymphatic Metastasis
- Middle Aged
- Ovarian Neoplasms
(genetics, metabolism, pathology)
- Risk Factors
- Vascular Endothelial Growth Factor C
(biosynthesis, genetics, metabolism)
|